Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 29907599

Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2018 Aug 16
First author
Porpaczy E

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2018 Aug 16;132(7):675-676. doi: 10.1182/blood-2018-07-858720.
    note
    Source null
    related pmid
    30115632
    relationship
    Comment in
  2. citation
    Blood. 2019 Feb 14;133(7):768. doi: 10.1182/blood-2019-01-895136.
    note
    Source null
    related pmid
    30765499
    relationship
    Erratum in

Authors and identifiers

  1. name
    Porpaczy E
    type
    Author
  2. name
    Tripolt S
    type
    Author
  3. name
    Hoelbl-Kovacic A
    type
    Author
  4. name
    Gisslinger B
    type
    Author
  5. name
    Bago-Horvath Z
    type
    Author
  6. name
    Casanova-Hevia E
    type
    Author
  7. name
    Clappier E
    type
    Author
  8. name
    Decker T
    type
    Author
  9. name
    Fajmann S
    type
    Author
  10. name
    Fux DA
    type
    Author
  11. name
    Greiner G
    type
    Author
  12. name
    Gueltekin S
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Porpaczy E
    type
    Author
  2. name
    Tripolt S
    type
    Author
  3. name
    Hoelbl-Kovacic A
    type
    Author
  4. name
    Gisslinger B
    type
    Author
  5. name
    Bago-Horvath Z
    type
    Author
  6. name
    Casanova-Hevia E
    type
    Author
  7. name
    Clappier E
    type
    Author
  8. name
    Decker T
    type
    Author
  9. name
    Fajmann S
    type
    Author
  10. name
    Fux DA
    type
    Author
  11. name
    Greiner G
    type
    Author
  12. name
    Gueltekin S
    type
    Author
bibliography ids
  1. nci-bib-362181d5bface14a85f25d19
book metadata
content sha256
b07a4ce53be2ca185de05dcaad87995bf918f8621f2b838820b896321ea906de
document type
citation
dois
  1. 10.1182/blood-2017-10-810739
electronic publication date
display
2018 Jun 14
precision
day
year
2018
evidence scope
bibliographic_metadata_only
id
pubmed:29907599
immutable id
pubmed:29907599@b07a4ce53be2ca185de05dcaad87995bf918f8621f2b838820b896321ea906de
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
7
name
Blood
nlm unique id
7603509
pages
694-706
volume
132
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2018 Aug 16;132(7):675-676. doi: 10.1182/blood-2018-07-858720.
    note
    Source null
    related pmid
    30115632
    relationship
    Comment in
  2. citation
    Blood. 2019 Feb 14;133(7):768. doi: 10.1182/blood-2019-01-895136.
    note
    Source null
    related pmid
    30765499
    relationship
    Erratum in
outcomes validated
false
pmid
29907599
provenance
batch id
c4c0356d060413f719c2
provider
NCBI PubMed ESummary
record sha256
6db5202b2f7c7a7b85b25de055a899e8e699e291fb78e9da90d0165e8ce5fa7d
response sha256
adeb6beaad718f060a94981fd9e96a2eaddc4f781839549cb3e53cba822117c0
retrieved at
2026-09-09T23:47:33.674758+00:00
publication date
display
2018 Aug 16
precision
day
year
2018
publication types
  1. Journal Article
  2. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29907599/
title
Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy.

Preserved source evidence · Not medical advice